CALGARY, Alberta, June 8 /PRNewswire/ -- An experimental drug called Reolysin® may give hope to patients suffering from advanced cancers, according to research presented at this year’s meeting of the American Society of Clinical Oncology (ASCO) -- the oncology community’s premier educational and scientific event.
